Barclays PLC grew its holdings in Elanco Animal Health Inc (NYSE:ELAT – Get Rating) by 2.8% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 82,745 shares of the company's stock after buying an additional 2,217 shares during the period. Barclays PLC's holdings in Elanco Animal Health were worth $1,730,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. McIlrath & Eck LLC acquired a new position in shares of Elanco Animal Health during the third quarter worth about $42,000. State Street Corp increased its stake in shares of Elanco Animal Health by 2.9% during the first quarter. State Street Corp now owns 216,200 shares of the company's stock worth $8,881,000 after acquiring an additional 6,000 shares during the period. Jane Street Group LLC acquired a new position in Elanco Animal Health during the first quarter worth about $391,000. Van ECK Associates Corp grew its position in Elanco Animal Health by 17.6% during the second quarter. Van ECK Associates Corp now owns 146,751 shares of the company's stock worth $4,702,000 after buying an additional 21,938 shares during the period. Finally, Federated Hermes Inc. grew its position in Elanco Animal Health by 30.2% during the second quarter. Federated Hermes Inc. now owns 96,347 shares of the company's stock worth $3,087,000 after buying an additional 22,356 shares during the period.

Analysts Set New Price Targets

Separately, TheStreet upgraded shares of Elanco Animal Health from a "d" rating to a "c-" rating in a research report on Monday, January 30th.

Elanco Animal Health Stock Up 1.0 %

Elanco Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 1st. Shareholders of record on Friday, January 13th were issued a $0.625 dividend. This represents a $2.50 annualized dividend and a dividend yield of 11.73%. The ex-dividend date was Thursday, January 12th.

Featured Articles

• Get a free copy of the StockNews.com research report on Elanco Animal Health (ELAT)
• MarketBeat Week in Review – 1/30 – 2/3
• Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
• Zimmer Biomet Beats on Earnings, Growth May be Priced In
• AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
• Ford Stock Going Forward After Big Earnings Flop

Want to see what other hedge funds are holding ELAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health Inc (NYSE:ELAT – Get Rating).

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.